• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Numira appoints David Raminick V.P. of sales & marketing

Numira appoints David Raminick V.P. of sales & marketing

March 28, 2014
CenterWatch Staff

Numira, a CRO providing high resolution, 3D imaging services, visualization software and cloud computing for the life science market, has appointed David Raminick vice president of sales and marketing.

As vice president, Raminick brings over 20 years of sales, marketing, business development and finance experience to the Numira team. Previously, Raminick was vice president of business development and strategy for Radiate Media, a digital and broadcast media organization where he supplied strategic leadership and direction by driving relationship development, product roadmap, contract negotiation and execution of industry partnerships. These efforts resulted in accelerating product time to market by six months and tripling average per customer monthly revenue. Additionally, he had an extensive automotive tenure in the Volkswagen of America (VWoA) organization holding key management roles for Audi, Volkswagen Credit/Audi Financial Services and the Volkswagen brand. While at VWoA, he created and implemented a highly successful turnaround strategy for an underperforming Sales District; developed marketing/incentive programs resulting in previously unattained sales growth for the Audi Brand; and developed and managed $0.5 billion budget for Audi Brand.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing